Magnesium Development
Holland, US · Founded 2014 · Delaware LLC · 1 known investors
Founders & leadership
MA
Matthew AhearnNamed on SEC filing
JO
Jeff OndrlaNamed on SEC filing
DR
Donald RunningNamed on SEC filing
MM
Matt MilanowksiNamed on SEC filing
RB
Robert BallNamed on SEC filing
SL
Stephen LeBeauNamed on SEC filing
Board
MD
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 1 round · 2017
▶$2.5MraisedFeb 2019 · 9 investors · BiotechnologyRule 506(b)
▶$2.5MraisedFeb 2019 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew AhearnExecutive Officer
- Jeff OndrlaExecutive Officer
- Donald RunningExecutive Officer, Director
- Michael DeVriesDirector
- Matt MilanowksiDirector
- Robert BallExecutive Officer, Director
- Stephen LeBeauDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Minimum investment
- $100K
- Proceeds to insiders
- $200K
- First sale
- Sep 2017
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Magnesium Development's investors?
- Magnesium Development's investors include WMU Biosciences Research & Commercialization Center.
- How much funding has Magnesium Development raised?
- Magnesium Development has disclosed $2.5M raised across 1 round.
- Where is Magnesium Development headquartered?
- Magnesium Development is headquartered in Holland, US.